Journals A-Z
All Subjects
Free Journals
sciepub.com
International Journal of Clinical and Experimental Neurology
ISSN (Print): 2379-7789 ISSN (Online): 2379-7797 Website: https://www.sciepub.com/journal/ijcen Editor-in-chief: Zhiyou Cai, MD
Open Access
Journal Browser
Go
Issue 1, Volume 1
Article Metrics
  • 24930
    Views
  • 20192
    Saves
  • 0
    Citations
  • 36
    Likes
Export Article
International Journal of Clinical and Experimental Neurology. 2013, 1(1), 5-11
DOI: 10.12691/ijcen-1-1-2
Open AccessArticle

Neural Stem Cell Transplantation Inhibits Apoptosis through Activation of MAPK/ERK Signaling Pathway in Cerebral Ischemia/Reperfusion Rats

Yu Zhao1, and Shijun Wang2

1Department of Neurology, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China

2Department of Otorhinolaryngology, the First Affiliated Hospital of Jiamushi University, Jiamushi, Heilongjiang Province, China

Pub. Date: November 07, 2013
View Full Text Full Text PDF (361 KB) Full Text ePUB(592 KB)

Cite this paper:
Yu Zhao and Shijun Wang. Neural Stem Cell Transplantation Inhibits Apoptosis through Activation of MAPK/ERK Signaling Pathway in Cerebral Ischemia/Reperfusion Rats. International Journal of Clinical and Experimental Neurology. 2013; 1(1):5-11. doi: 10.12691/ijcen-1-1-2

Abstract

Apoptosis, a major pathogenesis of cerebral ischemia, is closely associated with the dysregulation of MAPK/ERK signaling pathway. The transplantation of neural stem cells (NSCs), as a therapeutic target of cerebral ischemia, could repair missing cells and the activation of endogenous cells to provide "self-repair". However, the neuroprotective mechanism of the transplantation of NSCs against cerebral ischemia injury is unclear. This study is to investigate the effect of the transplantation of NSCs on apoptosis and MAPK/ERK signaling in the cerebral ischemia/reperfusion rats to evaluate its neuroprotective role. These results suggest that the transplantation of NSCs provides a neuroprotective effect via decreasing neurological deficit and increasing the activity of MAPK/ERK signaling in MCAO-lesioned brains and restraining apoptosis. In view of the treatment and prevention of ischemic brain damage, the ability of NSCs to enhance the activity of MAPK/ERK signaling and inhibit apoptosis may be of great importance in the selection of neuroprotective agents.

Keywords:
neural stem cells apoptosis MAPK/ERK signaling cerebral ischemia

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 4

References:

[1]  Ovbiagele B, Nguyen-Huynh MN: Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics 2011, 8(3):319-329.
 
[2]  Tran J, Mirzaei M, Anderson L, Leeder SR: The epidemiology of stroke in the Middle East and North Africa. J Neurol Sci 2010, 295(1-2):38-40.
 
[3]  Luker JA, Bernhardt J, Grimmer-Somers KA: Age and gender as predictors of allied health quality stroke care. J Multidiscip Healthc 2011, 4:239-245.
 
[4]  Li N, Kong X, Ye R, Yang Q, Han J, Xiong L: Age-related differences in experimental stroke: possible involvement of mitochondrial dysfunction and oxidative damage. Rejuvenation Res 2011, 14(3):261-273.
 
[5]  Hayashi T, Kawashima S, Nomura H, Itoh H, Watanabe H, Ohrui T, Yokote K, Sone H, Hattori Y, Yoshizumi M et al: Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients. Cardiovasc Diabetol 2011, 10(1):86.
 
[6]  Giantin V, Semplicini A, Franchin A, Simonato M, Baccaglini K, Attanasio F, Toffanello ED, Manzato E: Outcome after acute ischemic stroke (AIS) in older patients: effects of age, neurological deficit severity and blood pressure (BP) variations. Arch Gerontol Geriatr 2011, 52(3):e185-191.
 
[7]  Zhang P, Li J, Liu Y, Chen X, Lu H, Kang Q, Li W, Gao M: Human embryonic neural stem cell transplantation increases subventricular zone cell proliferation and promotes peri-infarct angiogenesis after focal cerebral ischemia. Neuropathology 2011, 31(4):384-391.
 
[8]  Yu F, Morshead CM: Adult stem cells and bioengineering strategies for the treatment of cerebral ischemic stroke. Curr Stem Cell Res Ther 2011, 6(3):190-207.
 
[9]  Lee HJ, Lim IJ, Lee MC, Kim SU: Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res 2010, 88(15):3282-3294.
 
[10]  Yamashita T, Deguchi K, Nagotani S, Abe K: Vascular protection and restorative therapy in ischemic stroke. Cell Transplant 2011, 20(1):95-97.
 
[11]  Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, Sun G, Manley NC, Pereira MP, Sheikh LA, McMillan EL et al: Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 2011, 134(Pt 6):1777-1789.
 
[12]  Zhao Y, Xie P, Zhu XF, Cai ZY: [Neural stem cell transplantation and nerve growth factor promote neurological recovery in rats with ischemic stroke]. Nan Fang Yi Ke Da Xue Xue Bao 2008, 28(7):1123-1126.
 
[13]  Wabnitz GH, Nebl G, Klemke M, Schroder AJ, Samstag Y: Phosphatidylinositol 3-kinase functions as a Ras effector in the signaling cascade that regulates dephosphorylation of the actin-remodeling protein cofilin after costimulation of untransformed human T lymphocytes. J Immunol 2006, 176(3):1668-1674.
 
[14]  Kwon DS, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK: Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells. Eur J Cell Biol 2006, 85(11):1189-1199.
 
[15]  Madala SK, Schmidt S, Davidson C, Ikegami M, Wert S, Hardie WD: MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Biol 2011.
 
[16]  Kornasio R, Riederer I, Butler-Browne G, Mouly V, Uni Z, Halevy O: Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 2009, 1793(5):755-763.
 
[17]  Li Q, Han LP, Li ZH, Zhang JT, Tang MK: [Salvianolic acid B alleviate the disruption of blood-brain barrier in rats after cerebral ischemia-reperfusion by inhibiting MAPK pathway]. Yao Xue Xue Bao 2010, 45(12):1485-1490.
 
[18]  Melani A, Gianfriddo M, Vannucchi MG, Cipriani S, Baraldi PG, Giovannini MG, Pedata F: The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res 2006, 1073-1074:470-480.
 
[19]  He QP, Ding C, Li PA: Effects of hyperglycemic and normoglycemic cerebral ischemia on phosphorylation of c-jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK). Cell Mol Biol (Noisy-le-grand) 2003, 49(8):1241-1247.
 
[20]  Ferrer I, Friguls B, Dalfo E, Planas AM: Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia. Acta Neuropathol 2003, 105(5):425-437.
 
[21]  Maddahi A, Edvinsson L: Enhanced expressions of microvascular smooth muscle receptors after focal cerebral ischemia occur via the MAPK MEK/ERK pathway. BMC Neurosci 2008, 9:85.
 
[22]  Zhang Y, Yao W, Qiu J, Qian W, Zhu C, Zhang C: The involvement of down-regulation of Cdh1-APC in hippocampal neuronal apoptosis after global cerebral ischemia in rat. Neurosci Lett 2011.
 
[23]  Siegel C, Li J, Liu F, Benashski SE, McCullough LD: miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci U S A 2011, 108(28):11662-11667.
 
[24]  Connell BJ, Saleh M, Khan BV, Saleh TM: Apocynin may limit total cell death following cerebral ischemia and reperfusion by enhancing apoptosis. Food Chem Toxicol 2011.
 
[25]  Putcha GV, Harris CA, Moulder KL, Easton RM, Thompson CB, Johnson EM, Jr.: Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice. J Cell Biol 2002, 157(3):441-453.
 
[26]  NIH committee recommends against revising the Guide. Physiologist 2007, 50(1):23.
 
[27]  Yu H, Cao B, Feng M, Zhou Q, Sun X, Wu S, Jin S, Liu H, Lianhong J: Combinated transplantation of neural stem cells and collagen type I promote functional recovery after cerebral ischemia in rats. Anat Rec (Hoboken) 2010, 293(5):911-917.
 
[28]  Brannvall K, Bogdanovic N, Korhonen L, Lindholm D: 19-Nortestosterone influences neural stem cell proliferation and neurogenesis in the rat brain. Eur J Neurosci 2005, 21(4):871-878.
 
[29]  Lehner B, Sandner B, Marschallinger J, Lehner C, Furtner T, Couillard-Despres S, Rivera FJ, Brockhoff G, Bauer HC, Weidner N et al: The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival. Cell Tissue Res 2011, 345(3):313-328.
 
[30]  Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20(1):84-91.
 
[31]  Zhang F, Wang S, Signore AP, Chen J: Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke 2007, 38(8):2329-2336.
 
[32]  Harting MT, Sloan LE, Jimenez F, Baumgartner J, Cox CS, Jr.: Subacute neural stem cell therapy for traumatic brain injury. J Surg Res 2009, 153(2):188-194.
 
[33]  Luan Z, Yin GC, Hu XH, Qu SQ, Wu NH, Yan FQ, Qian YM, Jin HY, Gong XJ: [Treatment of an infant with severe neonatal hypoxic-ischemic encephalopathy sequelae with transplantation of human neural stem cells into cerebral ventricle]. Zhonghua Er Ke Za Zhi 2005, 43(8):580-583; discussion 580.
 
[34]  Yoshida H, Date I, Shingo T, Fujiwara K, Kobayashi K, Miyoshi Y, Ohmoto T: Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study. J Neurosurg 2003, 98(4):874-881.
 
[35]  Cai Z, Zhao Y, Yao S, Bin Zhao B: Increases in beta-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-kappaB pathway activation. Pharmacol Rep 2011, 63(2):381-391.
 
[36]  Onteniente B, Rasika S, Benchoua A, Guegan C: Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies. Mol Neurobiol 2003, 27(1):33-72.
 
[37]  Noh SJ, Lee SH, Shin KY, Lee CK, Cho IH, Kim HS, Suh YH: SP-8203 reduces oxidative stress via SOD activity and behavioral deficit in cerebral ischemia. Pharmacol Biochem Behav 2011, 98(1):150-154.
 
[38]  Friefeld SJ, Westmacott R, Macgregor D, Deveber GA: Predictors of quality of life in pediatric survivors of arterial ischemic stroke and cerebral sinovenous thrombosis. J Child Neurol 2011, 26(9):1186-1192.
 
[39]  Codaccioni JL, Velly LJ, Moubarik C, Bruder NJ, Pisano PS, Guillet BA: Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology 2009, 110(6):1271-1278.
 
[40]  Irving EA, Barone FC, Reith AD, Hadingham SJ, Parsons AA: Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 2000, 77(1):65-75.
 
[41]  Franceschini D, Giusti P, Skaper SD: MEK inhibition exacerbates ischemic calcium imbalance and neuronal cell death in rat cortical cultures. Eur J Pharmacol 2006, 553(1-3):18-27.
 
[42]  Chen ZB, Huang DQ, Niu FN, Zhang X, Li EG, Xu Y: Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-kappaB. J Cereb Blood Flow Metab 2010, 30(7):1356-1365.
 
[43]  Jia J, Chen X, Zhu W, Luo Y, Hua Z, Xu Y: CART protects brain from damage through ERK activation in ischemic stroke. Neuropeptides 2008, 42(5-6):653-661.
 
[44]  Park EM, Joh TH, Volpe BT, Chu CK, Song G, Cho S: A neuroprotective role of extracellular signal-regulated kinase in N-acetyl-O-methyldopamine-treated hippocampal neurons after exposure to in vitro and in vivo ischemia. Neuroscience 2004, 123(1):147-154.
 
[45]  Chen XQ, Lau LT, Fung YW, Yu AC: Inactivation of bad by site-specific phosphorylation: the checkpoint for ischemic astrocytes to initiate or resist apoptosis. J Neurosci Res 2005, 79(6):798-808.
 
[46]  Gakhar-Koppole N, Hundeshagen P, Mandl C, Weyer SW, Allinquant B, Muller U, Ciccolini F: Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway. Eur J Neurosci 2008, 28(5):871-882.
 
[47]  Gan HT, Tham M, Hariharan S, Ramasamy S, Yu YH, Ahmed S: Identification of ApoE as an autocrine/paracrine factor that stimulates neural stem cell survival via MAPK/ERK signaling pathway. J Neurochem 2011, 117(3):565-578.
 
[48]  Peng CH, Chiou SH, Chen SJ, Chou YC, Ku HH, Cheng CK, Yen CJ, Tsai TH, Chang YL, Kao CL: Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol 2008, 18(2):128-140.
 
[49]  Zhang P, Li J, Liu Y, Chen X, Kang Q, Zhao J, Li W: Human neural stem cell transplantation attenuates apoptosis and improves neurological functions after cerebral ischemia in rats. Acta Anaesthesiol Scand 2009, 53(9):1184-1191.
 
[50]  Abe K: [Gene-stem Cell therapy for ischemic stroke]. Brain Nerve 2009, 61(9):1043-1049.
 
[51]  Kameda M, Shingo T, Takahashi K, Muraoka K, Kurozumi K, Yasuhara T, Maruo T, Tsuboi T, Uozumi T, Matsui T et al: Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur J Neurosci 2007, 26(6):1462-1478.
 
[52]  Hsieh WY, Hsieh YL, Liu DD, Yang SN, Wu JN: Neural progenitor cells resist excitatory amino acid-induced neurotoxicity. J Neurosci Res 2003, 71(2):272-278.
 
[53]  Levison SW, Rothstein RP, Romanko MJ, Snyder MJ, Meyers RL, Vannucci SJ: Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells. Dev Neurosci 2001, 23(3):234-247.
 
[54]  Qu J, Zhao M, Teng Y, Zhang Y, Hou K, Jiang Y, Yang X, Shang H, Qu X, Liu Y: Interferon-alpha sensitizes human gastric cancer cells to TRAIL-induced apoptosis via activation of the c-CBL-dependent MAPK/ERK pathway. Cancer Biol Ther 2011, 12(6):494-502.
 
[55]  Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M: ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. Cancer Biol Ther 2010, 9(8):592-603.
 
[56]  Yu Zhao, Shengtao Yao, Shijun Wang. 2010. Neural stem cell transplantation in the hippocampus of rats with cerebral ischemia/reperfusion injury activated the phosphatidylinositol-3 kinase/Akt pathway and increased brain-derived neurotrophic factor expression. Neural Regeneration Research. 21(01):1605-1610.
 
Manuscript template